Pharmacokinetics of a Model Organic Nitrite Inhalant and its Alcohol Metabolite in Rats
Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used as drugs of abuse. Little is known regarding the bioavailability and disposition of volatile nitrites. In this study, the pharmacokinetics o...
Saved in:
Published in | Drug metabolism and disposition Vol. 28; no. 4; pp. 386 - 391 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
Elsevier Inc
01.04.2000
American Society for Pharmacology and Experimental Therapeutics |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used as drugs of abuse. Little is known regarding the bioavailability and disposition of volatile nitrites. In this study, the pharmacokinetics of a major organic nitrite inhalant, isobutyl nitrite (ISBN), and its primary metabolite, isobutyl alcohol (ISBA), were investigated after inhalation and i.v. administration. ISBN blood concentrations in the rat declined mono-exponentially with a half-life of 1.4 min and a blood clearance of 2.9 l/min/kg that vastly exceeded cardiac output (0.3 l/min/kg). Approximately 98% of ISBN was metabolized to ISBA, which declined monoexponentially with a half-life of 5.3 min when the infusion of ISBN was terminated. The bioavailability of inhaled ISBN, over a range of 300 to 900 ppm, was estimated to be 43%. After inhaled ISBN, the half-life of ISBA decreased approximately 4-fold (t1/2 inh = 1.5 min versus t1/2 i.v. = 5.3 min; P < .001), whereas no pharmacokinetic difference was observed for ISBN. Inhalation of another nitrite, isoamyl nitrite, accelerated the apparent clearance of ISBA, suggesting that nitrite inhalation could change the disposition of another compound. A pharmacokinetic model was developed to describe the concentration-time profile of ISBA and ISBN after inhalation and i.v. administration. |
---|---|
AbstractList | Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used as drugs of abuse. Little is known regarding the bioavailability and disposition of volatile nitrites. In this study, the pharmacokinetics of a major organic nitrite inhalant, isobutyl nitrite (ISBN), and its primary metabolite, isobutyl alcohol (ISBA), were investigated after inhalation and i.v. administration. ISBN blood concentrations in the rat declined mono-exponentially with a half-life of 1.4 min and a blood clearance of 2.9 l/min/kg that vastly exceeded cardiac output (0.3 l/min/kg). Approximately 98% of ISBN was metabolized to ISBA, which declined monoexponentially with a half-life of 5.3 min when the infusion of ISBN was terminated. The bioavailability of inhaled ISBN, over a range of 300 to 900 ppm, was estimated to be 43%. After inhaled ISBN, the half-life of ISBA decreased approximately 4-fold (t(1/2) inh = 1.5 min versus t(1/2) i.v. = 5.3 min; P <.001), whereas no pharmacokinetic difference was observed for ISBN. Inhalation of another nitrite, isoamyl nitrite, accelerated the apparent clearance of ISBA, suggesting that nitrite inhalation could change the disposition of another compound. A pharmacokinetic model was developed to describe the concentration-time profile of ISBA and ISBN after inhalation and i.v. administration.Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used as drugs of abuse. Little is known regarding the bioavailability and disposition of volatile nitrites. In this study, the pharmacokinetics of a major organic nitrite inhalant, isobutyl nitrite (ISBN), and its primary metabolite, isobutyl alcohol (ISBA), were investigated after inhalation and i.v. administration. ISBN blood concentrations in the rat declined mono-exponentially with a half-life of 1.4 min and a blood clearance of 2.9 l/min/kg that vastly exceeded cardiac output (0.3 l/min/kg). Approximately 98% of ISBN was metabolized to ISBA, which declined monoexponentially with a half-life of 5.3 min when the infusion of ISBN was terminated. The bioavailability of inhaled ISBN, over a range of 300 to 900 ppm, was estimated to be 43%. After inhaled ISBN, the half-life of ISBA decreased approximately 4-fold (t(1/2) inh = 1.5 min versus t(1/2) i.v. = 5.3 min; P <.001), whereas no pharmacokinetic difference was observed for ISBN. Inhalation of another nitrite, isoamyl nitrite, accelerated the apparent clearance of ISBA, suggesting that nitrite inhalation could change the disposition of another compound. A pharmacokinetic model was developed to describe the concentration-time profile of ISBA and ISBN after inhalation and i.v. administration. Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used as drugs of abuse. Little is known regarding the bioavailability and disposition of volatile nitrites. In this study, the pharmacokinetics of a major organic nitrite inhalant, isobutyl nitrite (ISBN), and its primary metabolite, isobutyl alcohol (ISBA), were investigated after inhalation and i.v. administration. ISBN blood concentrations in the rat declined mono-exponentially with a half-life of 1.4 min and a blood clearance of 2.9 l/min/kg that vastly exceeded cardiac output (0.3 l/min/kg). Approximately 98% of ISBN was metabolized to ISBA, which declined monoexponentially with a half-life of 5.3 min when the infusion of ISBN was terminated. The bioavailability of inhaled ISBN, over a range of 300 to 900 ppm, was estimated to be 43%. After inhaled ISBN, the half-life of ISBA decreased approximately 4-fold (t1/2 inh = 1.5 min versus t1/2 i.v. = 5.3 min; P < .001), whereas no pharmacokinetic difference was observed for ISBN. Inhalation of another nitrite, isoamyl nitrite, accelerated the apparent clearance of ISBA, suggesting that nitrite inhalation could change the disposition of another compound. A pharmacokinetic model was developed to describe the concentration-time profile of ISBA and ISBN after inhalation and i.v. administration. Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used as drugs of abuse. Little is known regarding the bioavailability and disposition of volatile nitrites. In this study, the pharmacokinetics of a major organic nitrite inhalant, isobutyl nitrite (ISBN), and its primary metabolite, isobutyl alcohol (ISBA), were investigated after inhalation and i.v. administration. ISBN blood concentrations in the rat declined mono-exponentially with a half-life of 1.4 min and a blood clearance of 2.9 l/min/kg that vastly exceeded cardiac output (0.3 l/min/kg). Approximately 98% of ISBN was metabolized to ISBA, which declined monoexponentially with a half-life of 5.3 min when the infusion of ISBN was terminated. The bioavailability of inhaled ISBN, over a range of 300 to 900 ppm, was estimated to be 43%. After inhaled ISBN, the half-life of ISBA decreased approximately 4-fold (t(1/2) inh = 1.5 min versus t(1/2) i.v. = 5.3 min; P <.001), whereas no pharmacokinetic difference was observed for ISBN. Inhalation of another nitrite, isoamyl nitrite, accelerated the apparent clearance of ISBA, suggesting that nitrite inhalation could change the disposition of another compound. A pharmacokinetic model was developed to describe the concentration-time profile of ISBA and ISBN after inhalation and i.v. administration. Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used as drugs of abuse. Little is known regarding the bioavailability and disposition of volatile nitrites. In this study, the pharmacokinetics of a major organic nitrite inhalant, isobutyl nitrite (ISBN), and its primary metabolite, isobutyl alcohol (ISBA), were investigated after inhalation and i.v. administration. ISBN blood concentrations in the rat declined mono-exponentially with a half-life of 1.4 min and a blood clearance of 2.9 l/min/kg that vastly exceeded cardiac output (0.3 l/min/kg). Approximately 98% of ISBN was metabolized to ISBA, which declined monoexponentially with a half-life of 5.3 min when the infusion of ISBN was terminated. The bioavailability of inhaled ISBN, over a range of 300 to 900 ppm, was estimated to be 43%. After inhaled ISBN, the half-life of ISBA decreased approximately 4-fold ( t 1/2 inh = 1.5 min versus t 1/2 i.v. = 5.3 min; P < .001), whereas no pharmacokinetic difference was observed for ISBN. Inhalation of another nitrite, isoamyl nitrite, accelerated the apparent clearance of ISBA, suggesting that nitrite inhalation could change the disposition of another compound. A pharmacokinetic model was developed to describe the concentration-time profile of ISBA and ISBN after inhalation and i.v. administration. |
Author | Fung, Ho-Leung Kielbasa, William |
Author_xml | – sequence: 1 givenname: William surname: Kielbasa fullname: Kielbasa, William – sequence: 2 givenname: Ho-Leung surname: Fung fullname: Fung, Ho-Leung |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1315821$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10725305$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0U1vFCEYB3Biauy2-hE0HLTRwygwMDPEg2kaW5u01vgSvZFnGNjBsrAC26bfvrPd9SVeeuLA7_9Anv8e2gkxGISeUvKaEtq8-UKIJJUUonnJ-CsqiOAVf4BmVDBaTXc_dtDsD9lFezn_JIRyXstHaJeSlomaiBn6_mmEtAAdL10wxemMo8WAz-NgPL5IcwhO44-uJFcMPg0jeAgFQxiwKxkfeh3H6PG5KdBHvzYu4M9Q8mP00ILP5sn23Effjt9_PfpQnV2cnB4dnlWaM1IqTrqhJqA7IwkwOoi6a6FrWi6EbLUFa6CXVlhJeSNFb4H1pG_7DpreckJsvY8ONnOXKf5amVzUwmVt_PRNE1dZtURKRimZ4LMtXPULM6hlcgtIN-r3KibwfAsga_A2QdAu_3U1FR2jExMbplPMORn7zyS1bkbdNaPWa1eMq7tmFJ9yb__LaVeguBhKAufvTb_YpEc3H69dMmq57c3H-Y1ineKq7prJvds4M-38ypmksnYmaDNMGV3UEN09L90C5Kyzdg |
CODEN | DMDSAI |
CitedBy_id | crossref_primary_10_1208_aapsj0903032 crossref_primary_10_1016_j_niox_2005_09_010 crossref_primary_10_1016_j_bcp_2011_04_005 crossref_primary_10_1007_s11481_006_9024_4 |
Cites_doi | 10.1007/978-1-4615-5347-2_29 10.1097/00001648-199205000-00004 10.1056/NEJM198806163182404 10.1016/S0378-4347(99)00331-X 10.1002/jps.2600740719 10.1016/S0022-3565(25)20352-4 10.1093/occmed/44.3.125 10.1016/S0006-2952(96)00602-8 10.1006/faat.1994.1122 10.1023/A:1018943613122 10.1016/S0140-6736(02)51392-1 10.1016/S0002-8703(66)80007-8 10.1093/oxfordjournals.aje.a116186 |
ContentType | Journal Article |
Copyright | 2000 American Society for Pharmacology and Experimental Therapeutics 2000 INIST-CNRS |
Copyright_xml | – notice: 2000 American Society for Pharmacology and Experimental Therapeutics – notice: 2000 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/S0090-9556(24)15054-4 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1521-009X |
EndPage | 391 |
ExternalDocumentID | 10725305 1315821 10_1016_S0090_9556_24_15054_4 28_4_386 S0090955624150544 |
Genre | Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: HL22273 |
GroupedDBID | --- .GJ 0R~ 18M 2WC 4.4 53G 5GY 5RE 5VS AAXUO ABJNI ABSQV ACGFO ACGFS ACIWK ACPRK ADBBV AENEX AERNN AFFNX AFOSN AFRAH AI. ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CS3 DIK DU5 E3Z EBS EJD F5P F9R FDB GX1 H13 HZ~ IH2 INIJC KQ8 LSO M41 O9- OK1 P2P R0Z RHI ROL RPT SJN TR2 VH1 W8F WH7 WOQ YCJ YHG ZGI ZXP ~KM - 08R 0R AAPBV AAWZA ABFLS ABSGY ADACO FH7 FRP GJ HZ KM O0- RHF W2D AALRI AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c420t-408d30ac8e90a21d5387a86745597cfafeab9f5f914695bfa2b0b7b8a6bf400f3 |
ISSN | 0090-9556 |
IngestDate | Sun Aug 24 03:59:55 EDT 2025 Wed Feb 19 01:43:19 EST 2025 Mon Jul 21 09:18:47 EDT 2025 Tue Jul 01 05:41:45 EDT 2025 Thu Apr 24 23:04:01 EDT 2025 Tue Jan 05 21:16:59 EST 2021 Sun Apr 06 06:52:59 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | NO ISBA ISBN ISAN Volatile compound Intravenous administration Rat Metabolite Nitrites Rodentia Metabolism Inhalation Toxicokinetics Vertebrata Mammalia Animal Distribution Organic nitrate Models Drug of abuse |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c420t-408d30ac8e90a21d5387a86745597cfafeab9f5f914695bfa2b0b7b8a6bf400f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 10725305 |
PQID | 70992110 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_70992110 pubmed_primary_10725305 pascalfrancis_primary_1315821 crossref_primary_10_1016_S0090_9556_24_15054_4 crossref_citationtrail_10_1016_S0090_9556_24_15054_4 highwire_pharmacology_28_4_386 elsevier_sciencedirect_doi_10_1016_S0090_9556_24_15054_4 |
ProviderPackageCode | RHF RHI CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2000-04-01 |
PublicationDateYYYYMMDD | 2000-04-01 |
PublicationDate_xml | – month: 04 year: 2000 text: 2000-04-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Bethesda, MD |
PublicationPlace_xml | – name: Bethesda, MD – name: United States |
PublicationTitle | Drug metabolism and disposition |
PublicationTitleAlternate | Drug Metab Dispos |
PublicationYear | 2000 |
Publisher | Elsevier Inc American Society for Pharmacology and Experimental Therapeutics |
Publisher_xml | – name: Elsevier Inc – name: American Society for Pharmacology and Experimental Therapeutics |
References | de Leon, Perloff (bib6) 1965; 72 Akerboom, Ji, Wagner, Sies (bib1) 1997; 53 Archibald, Schechter, Le, Craib, Montaner, O’Shaughnessy (bib2) 1993; 3 Farris, Griffith (bib7) 1949 Kowaluk, Fung (bib9) 1991; 259 Kielbasa, Bauer, Fung (bib8) 1999; 734 Bauer, Fung (bib3) 1995; 7 Seague, Mayer, Horsburgh, Holmberg, Moon, Lamb (bib15) 1992; 135 Slaughter, Coleman, Gaudette, McKee, Masten, Gardiner, Strother, Tyler, Jeffcoat (bib16) 1994; 23 Maickel, McFadden (bib11) 1979; 26 Brunton (bib4) 1867; 2 National Institute on Drug Abuse (1996) www.nida.nih.gov/NIDACapsules/NCInhalants.html Osterloh, Goldfield (bib14) 1984; 74 Davies, Morris (bib5) 1993; 10 Soderberg, Roy, Barnett (bib17) 1998; 437 Lembo, Dell’Italia, Crawford, O’Rourke (bib10) 1988; 318 Nicholson, Ferguson-Smith, Pemberton, Campbell, Edwards, Ferner (bib13) 1994; 44 Brunton (10.1016/S0090-9556(24)15054-4_bib4) 1867; 2 de Leon (10.1016/S0090-9556(24)15054-4_bib6) 1965; 72 Davies (10.1016/S0090-9556(24)15054-4_bib5) 1993; 10 Kielbasa (10.1016/S0090-9556(24)15054-4_bib8) 1999; 734 Kowaluk (10.1016/S0090-9556(24)15054-4_bib9) 1991; 259 Lembo (10.1016/S0090-9556(24)15054-4_bib10) 1988; 318 Nicholson (10.1016/S0090-9556(24)15054-4_bib13) 1994; 44 Akerboom (10.1016/S0090-9556(24)15054-4_bib1) 1997; 53 Maickel (10.1016/S0090-9556(24)15054-4_bib11) 1979; 26 10.1016/S0090-9556(24)15054-4_bib12 Soderberg (10.1016/S0090-9556(24)15054-4_bib17) 1998; 437 Archibald (10.1016/S0090-9556(24)15054-4_bib2) 1993; 3 Farris (10.1016/S0090-9556(24)15054-4_bib7) 1949 Osterloh (10.1016/S0090-9556(24)15054-4_bib14) 1984; 74 Seague (10.1016/S0090-9556(24)15054-4_bib15) 1992; 135 Bauer (10.1016/S0090-9556(24)15054-4_bib3) 1995; 7 Slaughter (10.1016/S0090-9556(24)15054-4_bib16) 1994; 23 |
References_xml | – volume: 734 start-page: 83 year: 1999 end-page: 89 ident: bib8 article-title: Analysis of isobutyl nitrite inhalant in rat and human blood: Application for pharmacokinetic investigations. publication-title: J Chromatogr B – volume: 259 start-page: 519 year: 1991 end-page: 525 ident: bib9 article-title: Vascular nitric oxide activities for organic nitrites and organic nitrates are distinct. publication-title: J Pharmacol Exp Ther – volume: 7 start-page: 17 year: 1995 end-page: 22 ident: bib3 article-title: Non-nitrate nitric oxide donors. publication-title: J Myocard Isch – volume: 44 start-page: 125 year: 1994 end-page: 128 ident: bib13 article-title: Time to discontinue the solutions A and B as a cyanide antidote. publication-title: Occup Med – volume: 23 start-page: 407 year: 1994 end-page: 420 ident: bib16 article-title: Disposition and pharmacokinetics of isopropanol in F-344 rats and B6C3F1 mice. publication-title: Fundam Appl Toxicol – volume: 318 start-page: 1572 year: 1988 end-page: 1578 ident: bib10 article-title: Bedside diagnosis of systolic murmurs. publication-title: N Engl J Med – volume: 135 start-page: 1 year: 1992 end-page: 11 ident: bib15 article-title: The relation between nitrite inhalants, unprotected receptive anal intercourse, and the risk of human immunodeficiency virus infection. publication-title: Am J Epidemiol – volume: 2 start-page: 97 year: 1867 ident: bib4 article-title: On the use of nitrite of amyl in angina pectoris. publication-title: Lancet – volume: 74 start-page: 780 year: 1984 end-page: 782 ident: bib14 article-title: Uptake of inhaled n-butyl nitrite and in vivo transformation in rats. publication-title: J Pharm Sci – volume: 53 start-page: 117 year: 1997 end-page: 120 ident: bib1 article-title: Subunit specificity and organ distribution of glutathione transferase-catalysed s-nitrosoglutathione formation from alkyl nitrites in the rat. publication-title: Biochem Pharmacol – volume: 437 start-page: 265 year: 1998 end-page: 268 ident: bib17 article-title: Isobutyl nitrite liberates nitric oxide which is not responsible for the immunotoxicity of the inhalant. publication-title: Adv Exp Med Biol – reference: National Institute on Drug Abuse (1996) www.nida.nih.gov/NIDACapsules/NCInhalants.html – volume: 26 start-page: 75 year: 1979 end-page: 83 ident: bib11 article-title: Acute toxicology of butyl nitrites and butyl alcohols. publication-title: Res Comm Chem Pathol Pharmacol – volume: 3 start-page: 203 year: 1993 end-page: 209 ident: bib2 article-title: Evidence for a sexually transmitted co-factor for AIDS-related Kaposi’s Sarcoma in a cohort of homosexual men. publication-title: Epidemiol – volume: 72 start-page: 337 year: 1965 end-page: 344 ident: bib6 article-title: The pulmonary hemodynamic effects of amyl nitrite in normal man. publication-title: Am Heart J – volume: 10 start-page: 1093 year: 1993 end-page: 1095 ident: bib5 article-title: Physiological parameters in laboratory animals and humans. publication-title: Pharm Res – year: 1949 ident: bib7 article-title: The Rat in Laboratory Investigation – volume: 437 start-page: 265 year: 1998 ident: 10.1016/S0090-9556(24)15054-4_bib17 article-title: Isobutyl nitrite liberates nitric oxide which is not responsible for the immunotoxicity of the inhalant. publication-title: Adv Exp Med Biol doi: 10.1007/978-1-4615-5347-2_29 – volume: 3 start-page: 203 year: 1993 ident: 10.1016/S0090-9556(24)15054-4_bib2 article-title: Evidence for a sexually transmitted co-factor for AIDS-related Kaposi’s Sarcoma in a cohort of homosexual men. publication-title: Epidemiol doi: 10.1097/00001648-199205000-00004 – volume: 318 start-page: 1572 year: 1988 ident: 10.1016/S0090-9556(24)15054-4_bib10 article-title: Bedside diagnosis of systolic murmurs. publication-title: N Engl J Med doi: 10.1056/NEJM198806163182404 – ident: 10.1016/S0090-9556(24)15054-4_bib12 – year: 1949 ident: 10.1016/S0090-9556(24)15054-4_bib7 – volume: 734 start-page: 83 year: 1999 ident: 10.1016/S0090-9556(24)15054-4_bib8 article-title: Analysis of isobutyl nitrite inhalant in rat and human blood: Application for pharmacokinetic investigations. publication-title: J Chromatogr B doi: 10.1016/S0378-4347(99)00331-X – volume: 74 start-page: 780 year: 1984 ident: 10.1016/S0090-9556(24)15054-4_bib14 article-title: Uptake of inhaled n-butyl nitrite and in vivo transformation in rats. publication-title: J Pharm Sci doi: 10.1002/jps.2600740719 – volume: 259 start-page: 519 year: 1991 ident: 10.1016/S0090-9556(24)15054-4_bib9 article-title: Vascular nitric oxide activities for organic nitrites and organic nitrates are distinct. publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)20352-4 – volume: 44 start-page: 125 year: 1994 ident: 10.1016/S0090-9556(24)15054-4_bib13 article-title: Time to discontinue the solutions A and B as a cyanide antidote. publication-title: Occup Med doi: 10.1093/occmed/44.3.125 – volume: 53 start-page: 117 year: 1997 ident: 10.1016/S0090-9556(24)15054-4_bib1 article-title: Subunit specificity and organ distribution of glutathione transferase-catalysed s-nitrosoglutathione formation from alkyl nitrites in the rat. publication-title: Biochem Pharmacol doi: 10.1016/S0006-2952(96)00602-8 – volume: 7 start-page: 17 year: 1995 ident: 10.1016/S0090-9556(24)15054-4_bib3 article-title: Non-nitrate nitric oxide donors. publication-title: J Myocard Isch – volume: 23 start-page: 407 year: 1994 ident: 10.1016/S0090-9556(24)15054-4_bib16 article-title: Disposition and pharmacokinetics of isopropanol in F-344 rats and B6C3F1 mice. publication-title: Fundam Appl Toxicol doi: 10.1006/faat.1994.1122 – volume: 10 start-page: 1093 year: 1993 ident: 10.1016/S0090-9556(24)15054-4_bib5 article-title: Physiological parameters in laboratory animals and humans. publication-title: Pharm Res doi: 10.1023/A:1018943613122 – volume: 2 start-page: 97 year: 1867 ident: 10.1016/S0090-9556(24)15054-4_bib4 article-title: On the use of nitrite of amyl in angina pectoris. publication-title: Lancet doi: 10.1016/S0140-6736(02)51392-1 – volume: 72 start-page: 337 year: 1965 ident: 10.1016/S0090-9556(24)15054-4_bib6 article-title: The pulmonary hemodynamic effects of amyl nitrite in normal man. publication-title: Am Heart J doi: 10.1016/S0002-8703(66)80007-8 – volume: 135 start-page: 1 year: 1992 ident: 10.1016/S0090-9556(24)15054-4_bib15 article-title: The relation between nitrite inhalants, unprotected receptive anal intercourse, and the risk of human immunodeficiency virus infection. publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a116186 – volume: 26 start-page: 75 year: 1979 ident: 10.1016/S0090-9556(24)15054-4_bib11 article-title: Acute toxicology of butyl nitrites and butyl alcohols. publication-title: Res Comm Chem Pathol Pharmacol |
SSID | ssj0014439 |
Score | 1.6606156 |
Snippet | Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used... Volatile organic nitrites were originally used to relieve the chest pain that is associated with angina pectoris. Today, these inhalants are predominantly used... |
SourceID | proquest pubmed pascalfrancis crossref highwire elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 386 |
SubjectTerms | Administration, Inhalation Alcohols - blood Alcohols - metabolism Animals Biological and medical sciences Biotransformation Cardiac Output - drug effects Drug addictions Half-Life Infusions, Intravenous Male Medical sciences Nitrites - administration & dosage Nitrites - blood Nitrites - pharmacokinetics Rats Rats, Sprague-Dawley Toxicology Vasodilator Agents - administration & dosage Vasodilator Agents - blood Vasodilator Agents - pharmacokinetics |
Title | Pharmacokinetics of a Model Organic Nitrite Inhalant and its Alcohol Metabolite in Rats |
URI | https://dx.doi.org/10.1016/S0090-9556(24)15054-4 http://dmd.aspetjournals.org/content/28/4/386.abstract https://www.ncbi.nlm.nih.gov/pubmed/10725305 https://www.proquest.com/docview/70992110 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLfKuHBBfBNgwweYQFu6xHES-1igqMBAQ2vFbpadxICY2mlND3DmD-c5dhJ3MBW4RG1kx21-Pz-_Z78PhJ5UWcUynaowzZIypCWNQlbCfCwUlTLjvCyJCXB-_yGbzOjbk_RkMPjpeS2tajUsfvwxruR_UIV7gKuJkv0HZLuHwg34DPjCFRCG619hfOTyTn8DVbFJt9wEOzbFbVy5pmIPpizY_yY1yBfjxVh3pwXSFsc1NaSBCKe2zR4QYukrrK_OV5-7Jq6eRvm18_Xq5PWb8eGL0fGoc9lrODGzAVGTYXi4trsQeU4pvUO_kTSeD-lRn1Tb5oga-8UIpn3cmL_dGPEo5KlNIt5KXsI8hlFPjCZtemz7zdbz-k3Y232H4-7RoJIT-pRw0HFT6mKH1hJsX1j4OnfEOIlNvPAVdJWAsWGk5buP_VkUpYk1otwwfRzYQT_2M0Kfu3Ev03C6BNTG_1YuYQpqWzvlcuOmUXKmN9B1Z53gkaXaTTSo5rfQrkPi-z723_o-3sU-RrfRp4t8xAuNJW74iB0fseMjbvmIAVoMfMSOj7jnI7TBho930Oz1ePpyErrCHWFBSVSHNGJlEsmCVTySJC5hUc0ly3JqzNdCS11JxXWqOSzTPFVaEhWpXDGZKQ1rik7uoq35Yl7dR7hQmdYszxVnBWj2BYujRFck50wnYKzEAaLtyxaFy2pviqucit59ETASBiNBqGgwEjRAw67bmU3rsqkDa5EUTje1OqcANm7qutMiL848WARhggqgeoC21_jQ_yLLywA9bvkhQPibEz05rxarpcjBvjM7OAG6Z2nj_ZmcpLCWP9jw7IfoWj_tH6Gt-nxVbYOaXaudZhb8AoHB0Gw |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacokinetics+of+a+model+organic+nitrite+inhalant+and+its+alcohol+metabolite+in+rats&rft.jtitle=Drug+metabolism+and+disposition&rft.au=KIELBASA%2C+W&rft.au=FUNG%2C+H.-L&rft.date=2000-04-01&rft.pub=American+Society+for+Pharmacology+and+Experimental+Therapeutics&rft.issn=0090-9556&rft.volume=28&rft.issue=4&rft.spage=386&rft.epage=391&rft_id=info:doi/10.1016%2FS0090-9556%2824%2915054-4&rft.externalDBID=n%2Fa&rft.externalDocID=1315821 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0090-9556&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0090-9556&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0090-9556&client=summon |